Local delivery of IL-21 through oncolytic viruses offers several advantages, such as targeted delivery to tumor cells, reduced systemic toxicity, increased immune cell infiltration in tumor mass, enhanced therapeutic efficacy, a modified tumor microenvironment (TME), and immune-cell efficacy promotion.12 Here, IL21 is linked to neoplasm.